Benzz 45 mg Injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Benzz 45 mg Injection

Benzz 45 mg Injection

Benzz 45 mg Injection contains bendamustine 45 mg and is an injectable anticancer medicine. It is used for certain blood cancers, including chronic lymphocytic leukemia and non-Hodgkin lymphoma. The injection is administered by a healthcare professional through intravenous infusion under specialist supervision.

BUY NOW

Category

Bendamustine is an alkylating chemotherapy medicine that damages the DNA of cancer cells and interferes with their growth and multiplication. Benzz may be used alone or in combination with other medicines according to the prescribed treatment protocol. Regular monitoring of blood counts and organ function is important because treatment can cause anemia, reduced white blood cells, infections, fatigue, nausea, and other adverse effects. The dosage and treatment schedule are individualized by the treating oncologist according to the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Bendamustine
Strength 45 mg
Dosage Form Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial
Manufacturer / Marketer Intas Pharmaceuticals Ltd

Product Also Known As

Benzz 45mg Injection, Benzz 45 mg Injection, Bendamustine 45mg Injection, Bendamustine 45 mg Injection, Bendamustine Hydrochloride 45mg Injection, Bendamustine Oncology Injection